Aytu BioPharma, Inc. Reports Fiscal 2026 Q4 Results

What Happened

• On September 22, 2026, Aytu BioPharma, Inc. announced its fiscal 2026 fourth-quarter operational and financial results via a press release and scheduled a conference call and live webcast for the same day at 4:30 p.m. Eastern to discuss the results and take questions.
• The press release was furnished as Exhibit 99.1 to the Form 8-K. The company noted the press release content is furnished (not “filed”) under Section 18 of the Exchange Act.

Key Details

• Date of announcement: September 22, 2026.
• Conference call/webcast: scheduled for September 22, 2026 at 4:30 p.m. ET; available live and as a telephone and website replay.
• Press release furnished as Exhibit 99.1 to the 8-K; replay availability on the company website and by phone is at the company’s discretion and may be discontinued at any time.
• Filing item: 2.02 (Results of Operations and Financial Condition).

Why It Matters

• The company publicly released its quarterly operational and financial results and provided a same-day forum (call/webcast) where management will discuss performance and answer investor questions — an important opportunity to hear details on earnings, revenue, trends, and near-term outlook.
• Because the press release is furnished but not “filed” under Section 18, legal liability and incorporation-by-reference rules differ from other filed disclosures; investors should review the press release and listen to the call for the substantive financial figures and management commentary.